Roche to Buy InterMune for US$8.3 B to Gain Pirfenidone for Idiopathic Pulmonary Fibrosis
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 9 (Table of Contents)
Published: 24 Sep-2014
DOI: 10.3833/pdr.v2014.i9.2063 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its fifth M&A deal of 2014 so far, Roche has agreed to buy its former partner InterMune for approximately US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS